173 related articles for article (PubMed ID: 23792486)
1. Green or yellow laser treatment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network.
Bressler SB; Almukhtar T; Aiello LP; Bressler NM; Ferris FL; Glassman AR; Greven CM;
Retina; 2013; 33(10):2080-8. PubMed ID: 23792486
[TBL] [Abstract][Full Text] [Related]
2. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Elman MJ; Bressler NM; Qin H; Beck RW; Ferris FL; Friedman SM; Glassman AR; Scott IU; Stockdale CR; Sun JK;
Ophthalmology; 2011 Apr; 118(4):609-14. PubMed ID: 21459214
[TBL] [Abstract][Full Text] [Related]
3. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
; Elman MJ; Aiello LP; Beck RW; Bressler NM; Bressler SB; Edwards AR; Ferris FL; Friedman SM; Glassman AR; Miller KM; Scott IU; Stockdale CR; Sun JK
Ophthalmology; 2010 Jun; 117(6):1064-1077.e35. PubMed ID: 20427088
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.
; Googe J; Brucker AJ; Bressler NM; Qin H; Aiello LP; Antoszyk A; Beck RW; Bressler SB; Ferris FL; Glassman AR; Marcus D; Stockdale CR
Retina; 2011 Jun; 31(6):1009-27. PubMed ID: 21394052
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.
Bressler SB; Glassman AR; Almukhtar T; Bressler NM; Ferris FL; Googe JM; Gupta SK; Jampol LM; Melia M; Wells JA;
Am J Ophthalmol; 2016 Apr; 164():57-68. PubMed ID: 26802783
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.
; Elman MJ; Qin H; Aiello LP; Beck RW; Bressler NM; Ferris FL; Glassman AR; Maturi RK; Melia M
Ophthalmology; 2012 Nov; 119(11):2312-8. PubMed ID: 22999634
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Elman MJ; Ayala A; Bressler NM; Browning D; Flaxel CJ; Glassman AR; Jampol LM; Stone TW;
Ophthalmology; 2015 Feb; 122(2):375-81. PubMed ID: 25439614
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
Bressler SB; Qin H; Beck RW; Chalam KV; Kim JE; Melia M; Wells JA;
Arch Ophthalmol; 2012 Sep; 130(9):1153-61. PubMed ID: 22965591
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Dewan V; Lambert D; Edler J; Kymes S; Apte RS
Ophthalmology; 2012 Aug; 119(8):1679-84. PubMed ID: 22503301
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network
Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829
[TBL] [Abstract][Full Text] [Related]
12. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).
Comyn O; Sivaprasad S; Peto T; Neveu MM; Holder GE; Xing W; Bunce CV; Patel PJ; Egan CA; Bainbridge JW; Hykin PG
Am J Ophthalmol; 2014 May; 157(5):960-70. PubMed ID: 24531025
[TBL] [Abstract][Full Text] [Related]
14. Initial macular thickness and response to treatment in diabetic macular edema.
Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy for diabetic macular edema.
Al Rashaed S; Arevalo JF
Middle East Afr J Ophthalmol; 2013; 20(4):315-20. PubMed ID: 24339681
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema.
Aiello LP; Edwards AR; Beck RW; Bressler NM; Davis MD; Ferris F; Glassman AR; Ip MS; Miller KM;
Ophthalmology; 2010 May; 117(5):946-53. PubMed ID: 20122739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]